Email:
michaelhsiung@arkpharmtech.com
po@arkpharmtech.com
|
| Product Name | 4-(pyrimidin-2-ylmethyl)-7-(4-(trifluoromethoxy)phenyl)-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one |
| Synonyms | Eleclazine;PUY08529FK;4-(pyrimidin-2-ylmethyl)-7-[4-(trifluoromethoxy)phenyl]-2,3-dihydro-1,4-benzoxazepin-5-one;4-(pyrimidin-2-ylmethyl)-7-(4-(trifluoromethoxy)phenyl)-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one;1,4-Benzoxazepin-5(2H)-one, 3,4-dihydro-4-(2-pyrimidinylmethyl)-7-(4-(trifluoromethoxy)phenyl)-;1,4-Benzoxazepin-5(2H)-one, 3,4-dihydro-4-(2-pyrimidinylmethyl)-7-[4-(trifluoromethoxy)phenyl]-;Eleclazine [INN];Eleclazine [USAN:INN];Eleclazine (USAN/INN |
| Catalog No. | H-039271 |
| CAS No. | 1443211-72-0 |
| Molecular Formula | C21H16F3N3O3 |
| Molecular Weight | 415.3653 |
| Smile Code | FC(F)(OC1=CC=C(C2=CC3=C(C=C2)OCCN(C3=O)CC4=NC=CC=N4)C=C1)F |
| InChI | |
| EINECS | |
| Density | |
| Melting point | |
| Boiling point | |
| Refractive index | |
| Water solubility | |
| Hazard Symbols | |
| Risk Codes | |
| Safety Description |